An intricate web: Chemokine receptors, HIV-1 and hematopoiesis

Stem Cells

Volumn 16, Issue 2, 1998, Pages 79-88

  Lee, Benhur ^a   Doranz, Benjamin J ^a   Ratajczak, Mariusz Z ^a   Doms, Robert W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemokine receptors; Envelope; Hematopoiesis; HIV; Structure function

Indexed keywords

BETA CHEMOKINE RECEPTOR; CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; STEM CELL FACTOR; STEM CELL INHIBITORY FACTOR; UNCLASSIFIED DRUG;

GENE DELETION; GENETIC POLYMORPHISM; HEMATOPOIESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RESISTANCE; MACROPHAGE; PROTEIN EXPRESSION; PROTEIN INTERACTION; RECEPTOR DENSITY; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0031953962     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.160079     Document Type: Review

References (110)

1. Gottlieb MS, Schroff R, Schanker HM et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. Evidence of a new acquired cellular immunodeficiency. New Engl J Med 1982;305:1425-1431.
2. Dalgleish AG, Beverley PCL, Clapham PR et al. The CD4 (T4) antigen is an essential component of the receptor of the AIDS retrovirus. Nature 1984;312:763-767.
3. Klatzman D, Champagne E, Chamaret S et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984;312:767-768.
4. + cells by a complex of the 110K viral protein and the T4 molecule. Science 1986;231:382-385.
5. Maddon PJ, Dalgleish AG, McDougal JS et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986;47:333-385.
6. Chesebro B, Buller R, Portis J et al. Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. J Virol 1990;64:215-221.
7. Clapham PR, Blanc D, Weiss RA. Specific cell surface requirements for infection of CD4-positive cells by human immunodeficiency virus type 1, type 2 and simian immunodeficiency virus. Virology 1991;181:703-715.
8. Ashorn PA, Berger EA, Moss B. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cell. J Virol 1990;64:2149-2156.
9. Fisher AG, Ensoli B, Looney D et al. Biologically diverse molecular variants within a single HIV-1 isolate. Nature 1988:334:444-447.
10. Gartner S, Mokovits P, Markovits DM et al. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986;233:215-219.
11. + T cells. Science 1995;270:1811-1815.
12. Feng Y, Broder CC, Kennedy PE et al. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane domain, G-protein coupled receptor. Science 1996;272:872-877.
13. Bleui CC, Farazan M, Choe H et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/Fusin and blocks HIV-1 entry. Nature 1996;382:829-833.
14. Oberlin E, Amara A, Bachelerie F et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell line-adapted HIV-1. Nature 1996;382:833-835.
15. Samson M, Labbe O, Mollereau C et al. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996;35:3362-3367.
16. Alkhatib G, Combadiere C, Broder CC et al. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
17. Deng H, Liu R, Ellmeier W et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996;381:661-666.
18. Doranz BJ, Rucker J, Yi Y et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-1158.
19. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-673.
20. Choe H, Farzan M, Sun Y et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
21. Collman R, Balliet JW, Gregory SA et al. An infectious molecular clone of an unusal macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol 1992;66:7517-7521.
22. Shibata R, Hoggan MD, Broscius C et al. Isolation and characterization of a syncytium-inducing, macrophage/T-cell line -tropic human immunodeficeincy virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo. J Virol 1997;69:4453-4462.
23. Simmons G, Wilkinson D, Reeves JD et al. Primary, syncytium-inducing human immunodeficiency virus type I isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J Virol 1996;70:8355-8360.
24. Cho MW, Lee MK, Carney MC et al. Identification of determinants on a dual-tropic human immunodeficiency virus type-1 envelope glycoprotein that confer usage of CXCR4. J Virol 1998 (in press).
25. Connor RI, Sheridan KE, Ceradini D et al. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 1997;185:621-628.
26. Cheng-Mayer C, Liu R, Landau NR et al. Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor. J Virol 1997;71:1657-1661.
27. + hematopoietic progenitor cells. Blood 1997;89:3522-3528.
28. Endres MJ, Clapham PR, Marsh M et al. CD-I-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 1996;87:745-765.
29. Reeves JD, McKnight A, Potempa S et al. CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology 1997;231:130-134.
30. Dumonceauz J, Nicole S, Chanel C et al. Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J Virol 1998;72:512-518.
31. He J, Chen Y, Frazan M et al. CCR3 and CCR5 are coreceptors for HIV-1 infection of microglia. Nature 1997;385:645-649.
32. Shieh J, Albright A, Sharron M et al. Chemokine receptor utilization of HIV-1 isolates that replicate in microglia. J Virol 1998 (in press).
33. Bleul CC, Wu L, Hoxie JA et al. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997;94:1925-1930.
34. Unutmaz D, Littman DR. Expression pattern of HIV-I coreceptors on T cells: implications for viral transmission and lymphocyte homing. Proc Natl Acad Sci USA 1997;94:1615-1618.
35. Shirasaka T, Chokekijchai S, Yamada A et al. Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells. Antimicrob Agents Chemother 1995;39:2555-2559.
36. Gao WY, Agbaria R, Driscoll JS et al. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2′,3′-dideoxynucleoside analogs in resting and activated human cells. J Biol Chem 1994;269:12633-12638.
37. Gao WY, Shirasaka T, Johns DG et al. Differential phosphorylation of azidothymidine, dideoxycytidine, and didioxyinosine in resting and activated peripheral blood mononuclear cells. J Clin Invest 1997;100:2326-2333.
38. van'tWout AB, Ran LJ, Jong MDD et al. Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine and zidovudine, respectively. J Clin Invest 1997;100:2325-2332.
39. Levy JA. HIV pathogenesis and long-term survival. AIDS 1993;7:1401-1410.
40. Paxton WA, Martin SR, Tse D et al. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nat Med 1996;2:412-417.
41. Liu R, Paxton WA, Choe S et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-377.
42. Samson M, Libert F, Doranz BJ et al. Resistance to HIV-1 infection of Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996;382:722-725.
43. Rana S, Besson G, Cook DG et al. Role of CCR5 in infection of primary macrophages and lymphocytes by M-tropic strains of HIV: resistance to patient-derived and prototype isolates resulting from the Δccr5 mutation. J Virol 1997;71:3219-3227.
44. McNicholl JM, Smith DK, Qari SH et al. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele (Δ32CCR5). Emerg Infect Dis 1997;3:261-271.
45. Michael NL, Chang G, Louis LG et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997;3:338-340.
46. Huang Y, Pax ton WA, Wolinsky SM et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-1243.
47. Dean M, Carrington M, Winkler C et al. Genetic resistance of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-1862.
48. Eugenolsen J, Iverson AKN, Garred P et al. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of sero-positive individuals. AIDS 1997;11:305-310.
49. Zhang L, Carruthers CD, He T et al. HIV type I subtypes, coreceptor usage, and CCR5 polymorphism. AIDS Res Hum Retroviruses 1997;13:1357-1366.
50. Picchio GR, Gulizia RJ, Mosier DE. Chemokine receptor CCR5 genotype influences the kinetics of human immunodeficiency virus type I infection in human PBL-SCID mice. J Viroi 1997;71:7124-7127.
51. O'Brien TR, Winkler C, Dean M et al. HIV-1 infection in a man homozygous for CCR5-delta-32. Lancet 1997;349:1219.
52. Theodorou I, Meyer L, Magierowska M et al. HIV-1 infection in an individual homozygous for CCR5-delta-32. Lancet 1997;349:1219.
53. Biti R, French R, Young J et al. HIV-1 infection in an individual homozygous for the CCR5 deletion mutant. Nat Med 1997;3:252-253.
54. Martinson JL, Chapman NH, Rees DC et al. Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997;16:100-102.
55. Ansari-Lari MA, Liu XM, Metzker ML et al. The extent of genetic variation in the CCR5 gene. Nat Genet 1997;16:221-222.
56. Smith MW, Dean M, Carrington M et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-965.
57. McKeating JA, Willey RL. Structure and function of the HIV envelope. AIDS 1997;3(suppl 1):S35-S41.
58. Atchison RE, Gosling J, Monteclaro FS et al. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 1996;274:1924-1926.
59. Bieniasz PD, Fridell RA, Aramori I et al. HIV-1 induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 coreceptor. EMBO J 1997;16:2599-2609.
60. Doranz BJ, Lu Z, Rucker J et al. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J Virol 1997;71:6305-6314.
61. Rucker J, Samson M, Doranz BJ et al. Regions in β-chemokine receptors CKR-5 and CKR-2b that determine HIV-1 cofactor specificity. Cell 1996;87:437-446.
62. Lu Z, Berson JF, Chen Y et al. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc Natl Acad Sci USA 1997;94:6426-6431.
63. Brelot A, Heveker N, Pleskoff O et al. Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J Virol 1997;71:4744-4751.
64. Picard L, Wilkinson DA, McKnight A et al. Role of the aminoterminal extracellular domain of CXCR4 in human immunodeficiency virus type 1 entry. Virology 1997;231:105-111.
65. Kuhmann SE, Platt EJ, Kozak SL et al. Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses. J Virol 1997;71:8642-8656.
66. Alkhatib G, Locati M, Kennedy PE et al. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology 1997;234:340-348.
67. Chackerian B, Long EM, Luciw PA et al. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol 1997;71:3932-3939.
68. Farzan M, Choe H, Martin KA et al. HIV-1 entry and macrophage inflammatory protein 1β-mediated signaling are independent functions of the chemokine receptor CCR5. J Biol Chem 1997;272:6854-6857.
69. Gosling J, Monteclaro FS, Atchison RE et al. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc Natl Acad Sci USA 1997;94:5061-5066.
70. Weissman D, Rabin RL, Arthos J et al. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 1997;389:981-985.
71. Davis CB, Dikic I, Unutmaz D et al. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J Exp Med 1997;186:1793-1798.
72. Hwang SS, Boyle TJ, Lyerly HK et al. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991;253:71-74.
73. O'Brien WA, Koyanagi Y, Namazie A et al. HIV-tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain. Nature 1990;348:69-73.
74. DeJong J-J, Goudsmit J, Keulen W et al. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J Virol 1992;66:757-765.
75. Speck RF, Wehrly K, Platt EJ et al. Selective employment of chemokine receptors as human immunodeficiency virus type I coreceptors determined by individual amino acids within the envelope V3 loop. J Virol 1997;71:7136-7139.
76. Chen Z, Zhou P, Ho DD et al. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 1997;71:2705-2714.
77. Edinger AL, Amedee A, Miller K et al. Differential utilization of CCR5 by macrophage and T-cell tropic SIV strains. Proc Natl Acad Sci USA 1997;94:4005-4010.
78. Kirchhoff F, Pohlmann S, Harnacher M et al. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMX174 cells for efficient viral entry. J Virol 1997;71:6509-6516.
79. Deng H, Unutmaz D, Kewal Ramani VN et al. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997;388:296-300.
80. Farzan M, Choe H, Martin K et al. Two orphan seven-trans-membrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med 1997;186:405-411.
81. Edinger AL, Mankowski JL, Doranz BJ et al. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci USA 1997;94:14742-14747.
82. Martin KA, Wyatt R, Farzan M et al. CD4-independent binding of SIV gp120 to rhesus CCR5. Science 1997;278:1470-1473.
83. Aboulafia DM, Mitsuyasu RT. Hematologic abnormalities in AIDS. Hematol Oncol Clin N Am 1991;5:195-214.
84. Davis BR, Zauli G. Effect of human immunodeficiency virus infection on haematopoiesis. Baillieres Clin Haematol 1995;8:113-130.
85. Louache F, Debili N, Marandin A et al. Expression of CD4 by human hematopoietic progenitors. Blood 1994;84:3344-3355.
86. Chelucci C, Hassan HJ, Locardi C et al. In vitro human immunodeficiency virus-1 infection of purified hematopoietic progenitors in single-cell culture. Blood 1995;85:1181-1187.
87. + hematopoietic progenitors express low levels of CD4, the highaffinity receptor for human immunodeficiency virus-type I. Blood 1994;84:1896-1905.
88. Re MC, Furlini G, Zauli G et al. Human immunodeficiency virus type I (HIV-1) and human hematopoietic progenitor cells. Arch Virol 1994;137:1-23.
89. + bone marrow cells are infected with HIV in a subset of seropositive individuals. J Immunol 1992;149:689-697.
90. Bagnara GP, Zauli G, Giovannini M et al. Early loss of circulating hematopoietic progenitors in HIV-1 infected subjects. Exp Hematol 1990;18:4426-4433.
91. Louache F, Henri A, Bettaieb A et al. Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 1992;80:2991-2996.
92. Marandin A, Katz A, Oksenhendler E et al. Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection. Blood 1996;88:4568-4578.
93. Liao F, Alkhatib G, Peden KWC et al. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T-cell line-tropic HIV-1. J Exp Med 1997;185:2015-2023.
94. Rucker J, Edinger AL, Sharron M et al. Utilization of chemokine receptors, orphan receptors, and herpes virus encoded receptors by diverse human and simian immunodeficiency viruses. J Virol 1997;71:8999-9007.
95. Murphy MF, Metcalf P, Walters AH et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 1987;66:337-341.
96. Harbol AW, Liesveld JL, Simpson-Haidaris PJ et al. Mechanisms of cytopenia in human immunodeficiency virus infection. Blood Rev 1994;8:241-251.
97. Kozak SL, Platt EJ, Madani N et al. CD4, CXCR4, and CCR5 dependencies for infections by primary patient and laboratoryadapted isolates of human immunodeficiency virus type I. J Virol 1997;71:873-882.
98. Platt EJ, Wehrly K, Kuhnman SE et al. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type I. J Virol 1998 (in press).
99. Scadden DT, Zeira M, Woon A et al. Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood 1990;76:317-322.
100. Means RT. Pathogenesis of the anemia of chronic disease: a cytokine mediated anemia. STEM CELLS 1995;13:32-37.
101. Broxmeyer HE, Sherry B, Cooper S et al. Comparitive analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J Immunol 1993;150:3448-3455.
102. Mackewicz CE, Barker E, Greco G et al. Do beta-chemokinas have clinical relevance in HIV infection? J Clin Invest 1997;100:921-930.
103. Su S, Mukaida N, Wang J et al. Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1-alpha by interacting mainly with CC chemokine receptor, CCR1. Blood 1997;90:605-611.
104. Cook DN, Beck MA, Coffman TM et al. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 1995;269:1583-1587.
105. - cells selected from macrophage inflammatory protein 1 alpha + interleukin-3 supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells. Blood 1994;84:1442-1449.
106. Gerwirtz AM, Zhang J, Ratajczak J et al. Chemokine regulation of human megakaryocytopoiesis. Blood 1995;85:2559-2667.
107. Murakami T, Nakajima T, Koyanagi Y et al. A small molecule inhibitor that blocks T cell line-tropic HIV-I infection. J Exp Med 1997;186:1389-1393.
108. Schols D, Struyf S, VanDamme J et al. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 1997;186:1383-1388.
109. Doranz BJ, Grovit-Ferbas K, Sharron MP et al. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J Exp Med 1997;186:1395-1400.
110. Simmons G, Clapham PR, Picard L et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 1997;276:276-279.